Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vered Stearns

Showing results (1-10 of 273) with videos related to

Pageof 28
Sort By:
ACP Journal Club|November 4, 2006
Raloxifene and tamoxifen had similar efficacy for preventing invasive breast cancer in women at increased riskVered Stearns
The New England Journal of Medicine|July 12, 2018
TAILORing Adjuvant Systemic Therapy for Breast CancerVered Stearns
Current Oncology Reports|May 27, 2004
Management of hot flashes in breast cancer survivors and men with prostate cancerVered Stearns
The Journal of Supportive Oncology|August 9, 2006
More choices, more questions: weighing the options for treating hot flashesVered Stearns
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 19, 2019
Reply to H. Brauch et alVered Stearns
Treatments in Endocrinology|March 18, 2006
Serotonergic agents as an alternative to hormonal therapy for the treatment of menopausal vasomotor symptomsVered Stearns
Lancet (London, England)|June 26, 2007
Clinical update: new treatments for hot flushesVered Stearns
ACP Journal Club|January 4, 2008
A diet low in fat and high in vegetables, fruit, and fiber following breast cancer treatment did not reduce new breast cancer eventsVered Stearns
Evidence-Based Medicine|January 11, 2007
Raloxifene and tamoxifen had similar efficacy for preventing invasive breast cancer in women at increased riskVered Stearns
Annals of Internal Medicine|May 19, 2015
ACP Journal Club. Tamoxifen for 5 years reduced 16-year risk for breast cancer in women at increased riskHeather Parsons, Vered Stearns
Pageof 28

Showing results (1-10 of 273) with videos related to

Sort By:
Pageof 28
ACP Journal Club|November 4, 2006
Raloxifene and tamoxifen had similar efficacy for preventing invasive breast cancer in women at increased riskVered Stearns
The New England Journal of Medicine|July 12, 2018
TAILORing Adjuvant Systemic Therapy for Breast CancerVered Stearns
Current Oncology Reports|May 27, 2004
Management of hot flashes in breast cancer survivors and men with prostate cancerVered Stearns
The Journal of Supportive Oncology|August 9, 2006
More choices, more questions: weighing the options for treating hot flashesVered Stearns
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 19, 2019
Reply to H. Brauch et alVered Stearns
Treatments in Endocrinology|March 18, 2006
Serotonergic agents as an alternative to hormonal therapy for the treatment of menopausal vasomotor symptomsVered Stearns
Lancet (London, England)|June 26, 2007
Clinical update: new treatments for hot flushesVered Stearns
ACP Journal Club|January 4, 2008
A diet low in fat and high in vegetables, fruit, and fiber following breast cancer treatment did not reduce new breast cancer eventsVered Stearns
Evidence-Based Medicine|January 11, 2007
Raloxifene and tamoxifen had similar efficacy for preventing invasive breast cancer in women at increased riskVered Stearns
Annals of Internal Medicine|May 19, 2015
ACP Journal Club. Tamoxifen for 5 years reduced 16-year risk for breast cancer in women at increased riskHeather Parsons, Vered Stearns
Pageof 28